![](/img/cover-not-exists.png)
Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure
R.J. Kelly, A. Hill, L.M. Arnold, G. Khursigara, N.S. Kanagasundaram, P. HillmenVolume:
35
Year:
2011
Language:
english
Pages:
3
DOI:
10.1016/j.leukres.2010.10.021
File:
PDF, 110 KB
english, 2011